238 related articles for article (PubMed ID: 23763896)
1. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011.
Aagaard L; Hansen EH
BMC Pharmacol Toxicol; 2013 Jun; 14():30. PubMed ID: 23763896
[TBL] [Abstract][Full Text] [Related]
2. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
Aagaard L; Nielsen LH; Hansen EH
Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
[TBL] [Abstract][Full Text] [Related]
3. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011.
Aagaard L; Hansen EH
Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145
[TBL] [Abstract][Full Text] [Related]
4. Side effects of antineoplastic and immunomodulating medications reported by European consumers.
Aagaard L; Hansen EH
J Res Pharm Pract; 2013 Jan; 2(1):44-9. PubMed ID: 24991604
[TBL] [Abstract][Full Text] [Related]
5. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
7. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions in children reported by European consumers from 2007 to 2011.
Aagaard L; Hansen EH
Int J Clin Pharm; 2014 Apr; 36(2):295-302. PubMed ID: 24190692
[TBL] [Abstract][Full Text] [Related]
9. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
[TBL] [Abstract][Full Text] [Related]
10. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
Aagaard L; Hallgreen CE; Hansen EH
Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
[TBL] [Abstract][Full Text] [Related]
11. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.
Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL
Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091
[TBL] [Abstract][Full Text] [Related]
12. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries].
Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H
Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases.
Cliff-Eribo KO; Sammons H; Choonara I
Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085
[TBL] [Abstract][Full Text] [Related]
14. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
16. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
[TBL] [Abstract][Full Text] [Related]
17. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
18. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database.
Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E
Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109
[TBL] [Abstract][Full Text] [Related]
19. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
20. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database.
Lacroix C; Kheloufi F; Montastruc F; Bennis Y; Pizzoglio V; Micallef J
J Neurol Sci; 2019 Mar; 398():196-201. PubMed ID: 30683462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
